![]() |
Link a Tocris |
![]() |
Información esencial Tocris |
![]() |
Posters y Guias Tocris |
![]() |
Infromación Gnral Reactivos |
CCN3; IGFBP9; NOVH; IBP-9; Insulin-like growth factor-binding protein 9; Protein NOV homolog
CD314; KLR-K1; KLR; NKG2-D; NKG2-D Type II Integral Membrane Protein; NK cell receptor D; NKG2-D-activating NK receptor
IGHE; Immunoglobulin Heavy Constant Epsilon; Ig epsilon chain C region
TP53; LFS1; TRP53; Li-Fraumeni Syndrome; Cellular tumor antigen p53; Antigen NY-CO-13; Phosphoprotein p53; Tumor suppressor p53
CCL3-L1; LD78; SCYA3L; SCYA3L1; MIP1AP; MIP1-Alpha-P; Small Inducible Cytokine A3-Like 1; Macrophage Inflammatory Protein 1-Alpha-P; Tonsillar Lymphocyte LD78 Beta
CD236; CD236R; GYP-C; PAS-2; GPC; GYPD; Ge; Glycoprotein Beta; Glycoconnectin; Gerbich Blood Group; Glycophorin-D; Sialoglycoprotein D
DOD; Protein(Peptidyl-Prolyl Cis/Trans Isomerase)NIMA-Interacting 1; Peptidyl-prolyl cis-trans isomerase Pin1; Rotamase Pin1
BIS; CAIR1; BAG Family Molecular Chaperone Regulator 3; Bcl-2-binding protein Bis; Docking protein CAIR-1
SEMAL; Hsema-I; Hsema-III; SEMA1; SEMAD; SEMAIII; SemD; Coll-1; Sema Domain,Immunoglobulin Domain(Ig),Transmembrane Domain(TM)and Short Cytoplasmic Domain 3A